SDC1 and neoplasm: In the above analysis, two novel populations of tumor cells with aberrant co-expression of T cell marker genes, including CD19+CD3+ (sub-C9) and CD138+CD3+ (sub-C11) were clearly identified, and were further validated by flow cytometry analysis in another cohort of 10 NDWM patients.